1.4 C
New York
March 8, 2021
Worship Media
Business

Global stocks sink after China coronavirus resurgence

BEIJING — Global stock markets and U.S. futures retreated Friday after a resurgence of coronavirus infections in China and a rise in cases in Southeast Asia.

London and Frankfurt opened lower and Shanghai, Hong Kong and Tokyo declined.

Optimism about the rollout of coronavirus vaccines was dented by a spike in infections in China, where the disease had been under control. The government is testing millions of people in Beijing and some other cities. Authorities have called on the public to avoid travel during February’s Lunar New Year holiday.

That has “raised some concerns among investors who, after a slow start to the global vaccine rollout, are debating how fast economies can vaccinate the most vulnerable and start returning to business as usual,” said Stephen Innes of Axi in a report.

In early trading, the FTSE 100 in London fell 0.5% to 6,680.13 and the DAX in Frankfurt retreated 0.5% to 13,834.85. The CAC 40 in France shed 0.6% to 5,557.42.

On Wall Street, futures for the benchmark S&P 500 index and Dow Jones Industrial Average were off 0.5%.

On Thursday, the S&P 500 ended up less than 0.1% after a day of chopping trading. The Dow lost less than 0.1%.

The tech-heavy Nasdaq composite climbed 0.6% to 13,530.91 after traders bid up shares in Big Tech stocks, including Apple, Amazon and Facebook.

In Asia, the Shanghai Composite Index declined 0.4% to 3,606.75 and the Nikkei 225 in Tokyo sank 0.4% to 28,631.45. The Hang Seng in Hong Kong lost 1.6% to 29,447.85.

The Kospi in South Korea, where the increase in virus cases has slowed, fell 0.6% to 3,140.63.

The S&P-ASX 200 in Sydney shed 0.3% to 6,800.40. India’s Sensex retreated 1.1% to 49,052.61. New Zealand advanced 1.7% while Singapore and Indonesia declined.

Stocks have risen on optimism vaccines developed by U.S., European and Chinese drug companies would allow economies to return to normal.

Markets also have been encouraged by the inauguration of President Joe Biden, who proposed a US$1.9 trillion economic aid package, including $1,600 cash payments for most Americans.

Those hopes have been jolted by an upsurge in infections and the emergence of new virus variants that might be more infectious.

China, where the pandemic began in late 2019, has reimposed travel controls after outbreaks in Beijing and other cities. The government is building isolation hospitals with thousands of beds in Hebei province, which abuts the capital.

On Friday, China reported 103 new infections, the 11th day with more than 100 confirmed cases.

“The resurgence of cases in China, namely in the largest cities of Beijing and Shanghai, ahead of the Chinese New Year holidays is a cause of concern,” said Mizuho Bank in a report.

The Chinese government has called on the public to avoid gatherings and travel during the Lunar New Year holiday, normally the year’s most important family event. That is likely to dent spending on gifts, banquets and tourism, but economists say industrial activity might benefit if employees stay at their jobs.

Deaths are rising in Indonesia while case numbers increase in Malaysia, Thailand and the Philippines.

Benchmark U.S. crude lost 78 cents to $52.35 per barrel in electronic trading on the New York Mercantile Exchange. The contract fell 11 cents on Thursday to $53.13. Brent crude, the price standard for international oils, shed 69 cents to $55.41 per barrel in London. It rose 2 cents the previous session to $56.10 a barrel.

The dollar strengthened to 103.65 yen from Thursday’s 103.52. The euro advanced to $1.2176 from $1.2160.

Click Here to Visit Orignal Source of Article https://www.ctvnews.ca/business/global-stocks-sink-after-china-coronavirus-resurgence-1.5277612

Related posts

Ann Taylor, Loft and Justice stores in Canada to close

CTV News

Shopify says most employees will permanently work remotely following COVID-19

CTV News

Japan’s justice minister says Ghosn’s escape inexcusable

CTV News

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy